Holding Company Skyrockets 460% From AI Bid

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.

Trade Smarter (Sponsored)

Get Funded to Trade – Without Risking Your Own Money

Most traders fail not from lack of skill, but from lack of time, discipline, or capital.

That’s where a fully automated AI trading system steps in—trading smarter, faster, and without emotion.

It helps you pass funding challenges and access prop firm capital from $50K to $1M+.

You keep up to 90% of the profits—without risking your own money.

[Apply Now] — Limited spots open this month

Markets 📈

Wall Street was slightly bearish on Monday, as investors were in wait-and-see mode before the Fed’s decision on the interest rate scheduled for later this week. The S&P 500 fell victim, ending its nine-day winning streak.

Market-Moving News 📈

Consumer 

Biggest Footwear Buyout Ever: Skechers Sold in All-Cash Deal

Skechers (NYSE: SKX) is being taken private in a $9.42 billion all-cash deal by 3G Capital, marking the footwear industry’s largest buyout to date. The $63-per-share price offers a 28% premium over recent trading levels, providing a clear exit for shareholders after a challenging year.

High U.S. tariffs of 145% on Chinese imports, a key supply source, have hurt Skechers. The company also canceled its 2025 forecast amid falling demand, with shares down nearly 30% this year. Going private frees Skechers to strategize without public market pressure.

For investors, this buyout is a win. The $63-per-share payout delivers strong returns after a tough period, and selling now avoids further tariff-related losses. This deal boosts SKX’s value for shareholders, offering cash at a good price.

Other brands like Nike and Adidas face similar tariff pressures and lobbied to exempt footwear from import fees. Skechers’ choice to go private suggests restructuring is a better path than waiting out global uncertainty.

The buyer, 3G Capital, is known for cost-cutting and may reshape Skechers to handle ongoing market challenges. Current management will stay, but major operational shifts are likely without stock market oversight.

This move raises questions about whether other footwear brands might leave public markets. We’ll monitor how this buyout affects Skechers’ future and industry trends.

Crypto Edge (Sponsored)

Outperform Bitcoin—Without Owning It

Bitcoin’s ups and downs have made and lost fortunes. But what if there was a way to outperform BTC—without ever buying it?

Hedge fund titan Larry Benedict has revealed a new approach called "Bitcoin Skimming," a strategy that has outpaced Bitcoin’s returns by as much as 22-to-1.

With the SEC’s latest decision set to shake up crypto markets, now is the perfect time to discover how this works.

Click here to see the full details before this opportunity disappears.

Food Productions

Tyson Foods Struggles as High Beef Prices Push Shoppers Away

Tyson Foods (NYSE: TSN) saw its stock drop after reporting weaker-than-expected quarterly sales. High beef prices, driven by years of drought, are hurting demand, and cautious spending adds pressure.

Earnings beat forecasts, but revenue fell short, and Tyson kept its yearly outlook unchanged. Investors hoped strong chicken sales would lift guidance, but beef, the company’s biggest segment, is dragging results. Shoppers are choosing cheaper proteins like chicken and cutting beef sales.

Tyson’s beef troubles could weigh on its stock, worrying investors as this signals risk. Tyson’s $181 million loss in beef this year shows costs are outpacing prices, which may keep TSN’s stock under pressure. A turnaround depends on lower beef prices or stronger demand, which are both uncertain now.

Tariffs and inflation make things tougher, as exports, though small, face disruptions. Tyson expects trade to stabilize eventually, but no quick fix is clear.

Consumer trends are shifting the protein market, with price-sensitive shoppers avoiding beef. Tyson, heavily tied to beef, faces a longer recovery than hoped. The company faces fluctuating costs and shifting consumer preferences, but its success depends on the ability to adapt quickly.

Uranium Demand (Sponsored)

On Behalf of Azincourt Energy Corp

Why Uranium’s Next Cycle Could Be Bigger Than 2007

With AI pushing power demand through the roof, nuclear is the only option.

Uranium demand is set to double. One junior may benefit most.

Tap here to unlock the name.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Real Estate

Ackman Grabs Control of Howard Hughes in $900M Deal

Howard Hughes Holdings (NYSE: HHH) landed a $900 million cash injection from Pershing Square, selling new shares at $100 each, a 48% premium. Pershing now owns 46.9% of the company, shaking up its future.

This deal brings bold changes. Two Pershing leaders will take top roles, and pay will be tied to stock growth, pushing for bigger ambitions. The company wants to branch out into businesses like insurance, acting less like a typical real estate firm.

This is exciting news for investors. The cash and Pershing’s influence could increase HHH’s stock as it diversifies. Our take: This move makes HHH a growth play, offering strong returns if new ventures succeed.

Real estate markets are tough, but this investment gives Howard Hughes room to innovate. Unlike traditional developers, it’s aiming to be a flexible platform, a rare model that could inspire others.

Pershing’s track record adds confidence. With nearly half the company under its control, big moves are coming. If Howard Hughes pulls this off, it could lead the sector to adapt to challenges without leaving public markets.

Hyperscale Data Inc [GPUS] $7.68 (+460.58%)

Hyperscale Data jumped after posting $25 million in Q1 revenue, beating preliminary estimates. It also reported a one-time $9.7 million gain and AI data center expansion plans.

Skechers U.S.A. [SKX] $61.39 (+24.35%)

Skechers soared after announcing a $9.4 billion buyout by 3G Capital, offering shareholders a 30% premium.

BioCryst Pharma Inc [BCRX] $11.04 (+23.63%)

BioCryst rose to its highest in two years after posting break-even earnings versus expectations of a loss and reporting revenue that beat estimates by 15%.

Integra LifeSciences [IART] $13.28 (-21.19%)

Integra LifeSciences was among the biggest losers today after missing Q1 earnings expectations, slashing profit guidance, and reporting weak segment performance despite steady revenue.

PTC Therapeutics [PTCT] $40.65 (-18.62%)

PTC Therapeutics tumbled as Phase 2 trial results for its Huntington’s disease drug showed positive biomarker effects but unclear clinical benefits, raising concerns about the drug’s approval process.

TG Therapeutics [TGTX] $37.68 (-13.26%)

TG Therapeutics shares fell despite beating revenue estimates, as the company reported disappointing earnings results in Q1.

Technology (Sponsored)

The NEXT Trillion Dollar Company?

It just signed a deal to get its tech in Apple's iPhone until 2040!

Online commenters are debating if this brand-new company will be the 7th trillion dollar stock.

Details on the controversy here.

That's it for today! Please write us back and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

*Standard message/carrier rates may apply.

Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.